First human experience with the 17-beta-estradiol–eluting stent
Authors:
- Alexandre AbizaidAAAlexandre Abizaid
- Mariano AlbertalMAMariano Albertal
- Marco A CostaMCMarco A Costa
- Andrea S AbizaidAAAndrea S Abizaid
- Rodolfo StaicoRSRodolfo Staico
- Fausto FeresFFFausto Feres
- Luiz A MattosLMLuiz A Mattos
- Amanda G.M.R SousaASAmanda G.M.R Sousa
- Jeffrey MosesJMJeffrey Moses
- Nicholas KipshidizeNKNicholas Kipshidize
- Gary S RoubinGRGary S Roubin
- Roxana MehranRMRoxana Mehran
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary ArteriesCirculation, 2003
- TAXUS ICirculation, 2003
- No delayed restenosis at 18 months after implantation of sirolimus‐eluting stentCatheterization and Cardiovascular Interventions, 2002
- Coronary intervention in the diabetic patient: Improved outcome following stent implantation compared with balloon angioplastyClinical Cardiology, 2002
- Coronary artery endothelial protection after local delivery of 17β-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial functionJACC, 2001
- Local delivery of 17-beta-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine modelJACC, 2000
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis after Initial Balloon AngioplastyNew England Journal of Medicine, 1998
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseNew England Journal of Medicine, 1994